Choueiri TK, Larkin JMG, Oya M, et al. First-line avelumab + axitinib therapy in patients (pts) with advanced renal cell carcinoma (aRCC): Results from a phase Ib trial. J Clin Oncol. 2017;35 (suppl; abstr 4504).
Mediahype van invloed op keuzes bij adjuvante behandeling melanoom?
apr 2019 | Dermato-oncologie, Immuuntherapie